Heidi M Staudacher

Aug 10, 2024 | advances.nutrition.org | Heidi M Staudacher

Keywords diet interventions feeding trials recommendations design conduct reporting Abbreviations BI (blinding index) DASH (Dietary Approaches to Stop Hypertension) FODMAP (Fermentable Oligosaccharides, Disaccharides, Monosaccharides And Polyols) SOP (Standard Operating Procedure) Quality design and execution of feeding trials is important to accurately fill the knowledge gaps that cannot be answered by dietary counseling trials alone, so that together, they can help inform evidence-based...

Mar 3, 2024 | insightplus.mja.com.au | Heidi M Staudacher

Irritable bowel syndrome frequently occurs with comorbid depression, but traditional treatment just targets the troubling gut symptoms. A recent study tells us a new dietary approach may be able to treat both. Irritable bowel syndrome (IBS) is a common gastrointestinal disorder that affects around 4% of the Australian population. People with IBS experience recurrent abdominal pain and altered bowel habits, often accompanied by other symptoms such as bloating.

Jan 2, 2024 | thelancet.com | Amy Loughman |Heidi M Staudacher

For people living with gastrointestinal conditions, maintaining gut health, loosely defined by the absence of gut symptoms and an optimal gut microbiome, is a delicate balance. As covered in a previous Food Matters column, the nature of therapeutic diets for these disorders can make it challenging to eat the varied diet thought to support an optimal gut microbiome. So, what other evidence-informed ways can potentially improve and maintain gut health?

Jun 2, 2023 | nature.com | Heidi M Staudacher |Christopher Black

AbstractIrritable bowel syndrome (IBS) affects 5–10% of the global population. Up to one-third of people with IBS also experience anxiety or depression. Gastrointestinal and psychological symptoms both drive health-care use in people with IBS, but psychological comorbidity seems to be more important for long-term quality of life. An integrated care approach that addresses gastrointestinal symptoms with nutrition and brain–gut behaviour therapies is considered the gold standard.